APA
Sellam J., Rivière E., Courties A., Rouzaire P., Tolusso B., Vital E. M., Emery P., Ferraccioli G., Soubrier M., Ly B., Hendel Chavez H., Taoufik Y., Dougados M. & Mariette X. (20171120). Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. : Arthritis research & therapy.
Chicago
Sellam Jérémie, Rivière Elodie, Courties Alice, Rouzaire Paul-Olivier, Tolusso Barbara, Vital Edward M, Emery Paul, Ferraccioli Gianfranco, Soubrier Martin, Ly Bineta, Hendel Chavez Houria, Taoufik Yassine, Dougados Maxime and Mariette Xavier. 20171120. Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. : Arthritis research & therapy.
Harvard
Sellam J., Rivière E., Courties A., Rouzaire P., Tolusso B., Vital E. M., Emery P., Ferraccioli G., Soubrier M., Ly B., Hendel Chavez H., Taoufik Y., Dougados M. and Mariette X. (20171120). Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. : Arthritis research & therapy.
MLA
Sellam Jérémie, Rivière Elodie, Courties Alice, Rouzaire Paul-Olivier, Tolusso Barbara, Vital Edward M, Emery Paul, Ferraccioli Gianfranco, Soubrier Martin, Ly Bineta, Hendel Chavez Houria, Taoufik Yassine, Dougados Maxime and Mariette Xavier. Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. : Arthritis research & therapy. 20171120.